Nanobots Therapeutics Analysis
What is Nanobots Therapeutics?
Unique therapeutic entities for targeted drug delivery
Employees
1-10
Founded
2023
Industry
Biotechnology
Interests
HEALTH/FITNESS/WELLBEING
Startup Tag
Yes
Product Features & Capabilities
- MotionTx platform for drug delivery
- NBT-101 for bladder cancer therapy
- NBT-102 for undisclosed indications
- Urease-powered nanobots for cancer therapy
- Enzyme-powered gated mesoporous silica nanomotors.
Use Cases
Enhance drug delivery to target cells; Improve treatment efficacy for bladder cancer; Develop novel drug modalities for various indications; Facilitate targeted delivery of therapeutic agents; Monitor in vivo behavior of nanomotors.
Other Considerations
Spin-off from ICREA and IBEC; Recognized with AECC IMPACTO grant; Closed a €1M seed funding round.
4 Yfn Page Information
Main Information
- Information: Nanobots Therapeutics is a health-focused, deeptech company developing the MotionTx platform, which enhances drug accumulation in target cells, with its first indication being bladder cancer.
- Interests: HEALTH/FITNESS/WELLBEING
- Location: Hall 8.1 - 4YFN Stand 8.1A40
- Whether tagged as startup: Yes
- LinkedIn: Not found
- Twitter: Not found
- Phone Number: Not found
- Email: Not found
- Growth Stage: Seed
- Country: Spain
- Founding Year: 2023
Company Context
---
Company Name: Nanobots Therapeutics; Company Website: https://www.nanobotstx.com/
---
Company Name: Nanobots Therapeutics; Company Website: https://www.nanobotstx.com/
See something that needs updating? Suggest edits to this profile.
